When will Compass Pathways submit a NDA for COMP360 psilocybin?
Health & MedicineOne-OffBilimBusiness & Corporate1ay
KalshiKullanılabilirliği kontrol etKYC gerekli%2 ücretDoğrulanmış sonuçlanma verisiKabaca kalibreGüncel ima edilen olasılıkbefore April 2027 85%6 seçenek arasında lider
Piyasa kalitesi
49 / 100
Düşük kalite24s Hacim
₺0
Likidite
₺226,9 B
Orta likiditeAlis / Satis
9.0% / 12.0%
Spread
3.0 pt
Orta spreadPiyasa verileri
23 dakika önce guncellendi
24 Mar 26 14:001 Eyl 26 14:00
Trendler
Yalnızca sanal bakiye, gerçek para yokYatırım tavsiyesi değildir
Seçilen sonuç
before September15%
Hacim trendi
$12 Tem19g veri25 Tem
İlgili Piyasalar
Which fast food chain in the USA will offer a lab-grown / cultivated meat product first?
₺5,8 BMc Donald's: 7%MANIFOLD MARKETS
MANIFOLD MARKETS
When will I be able to buy cultured meat at a random Whole Foods?
₺9,5 B2024: 0.5%MANIFOLD MARKETS
MANIFOLD MARKETSTestosterone unscheduled/rescheduled more permissively in US by end of 2028?
₺27,6 BEvet: 17.8%MANIFOLD MARKETS
MANIFOLD MARKETS
Will there be a year without polio before 2030?
₺832Evet: 6%KALSHI
KALSHI
Hantavirus vaccine in 2026?
₺49,8Evet: 6%
POLYMARKET
POLYMARKET
When will Intellia Therapeutics submit a BLA for Lonvo-z?
₺0before September: 22%KALSHI
KALSHIBu konularda aktif
İlgili Haberler
AMINA Bank weighs IPO after 69% revenue growthCrypto NewsAMINA Bank taps Cantor for potential public listingCrypto News
Metaplanet plans Bitcoin-backed bonds yielding up to 6%Crypto News
Bitmine keeps buying Ether as ETH outperforms BitcoinCointelegraph
NVIDIA Ising Calibration 1.5 Pushes Quantum Computing ForwardBlockchain.News
Fanatics buys regulated exchange in bid to grow prediction markets businessCoindeskKurallar
If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.